Affiliations 

  • 1 Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, 0811, Australia. Sarah.Auburn@menzies.edu.au
  • 2 Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK
  • 3 Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, UK
  • 4 Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, 0811, Australia
  • 5 Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, 88300, Kota Kinabalu, Sabah, Malaysia
  • 6 Eijkman Institute for Molecular Biology, Jakarta, 10430, Indonesia
  • 7 Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Tak, 63110, Thailand
Nat Commun, 2018 Jul 03;9(1):2585.
PMID: 29968722 DOI: 10.1038/s41467-018-04965-4

Abstract

The incidence of Plasmodium vivax infection has declined markedly in Malaysia over the past decade despite evidence of high-grade chloroquine resistance. Here we investigate the genetic changes in a P. vivax population approaching elimination in 51 isolates from Sabah, Malaysia and compare these with data from 104 isolates from Thailand and 104 isolates from Indonesia. Sabah displays extensive population structure, mirroring that previously seen with the emergence of artemisinin-resistant P. falciparum founder populations in Cambodia. Fifty-four percent of the Sabah isolates have identical genomes, consistent with a rapid clonal expansion. Across Sabah, there is a high prevalence of loci known to be associated with antimalarial drug resistance. Measures of differentiation between the three countries reveal several gene regions under putative selection in Sabah. Our findings highlight important factors pertinent to parasite resurgence and molecular cues that can be used to monitor low-endemic populations at the end stages of P. vivax elimination.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.